Investor Update from NSB Chairman Paul Rennie

September, 2022

NeuroScientific Biopharmaceuticals Chairman, Paul Rennie provides an investor update to discuss the recent rejection of the Company's HREC submission.

Further reading

September, 2022

NeuroScientific Biopharmaceuticals Investor Update Webinar

December, 2021

NeuroScientific Biopharmaceuticals Investor Webinar Presentation – ShareCafe Small Cap “Hidden Gems”

November, 2021

Broker Briefing Webinar with Dr Alexandra Andrews

September, 2021

Investor Webinar Presentation ShareCafe Small Cap “Hidden Gems” Webinar

Investor Update from NSB Chairman Paul Rennie

Subscribe for important NeuroScientific announcements and updates